Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson’s disease.
Synpromics Ltd, the leader in gene control, announces a collaboration with UCL Great Ormond Street Institute of Child Health, to develop novel gene therapies for pathologies affecting the haematopoietic system.
Ingenza announce collaboration with the University of Dundee and Drochaid Research Services on a highly innovative project that aims to reduce the waste carbon dioxide generated by industrial biotech manufacturing applications.
Ingenza, a leader in the application of industrial biotechnology and synthetic biology, is pleased to announce that it has become a stakeholder in Amprologix, a spin-out company from the University of Plymouth.
HRH, The Princess Royal, visited Easter Bush Campus in May 2018, to open the Charnock Bradley Building, Equine Diagnostic, Surgical and Critical Care Unit (EDSCCU) and unveil ‘Canter’, sculpture by 'The Kelpies' creator Andy Scott.
1851 Royal Commission Fellowship has funded innovative doctoral research with commercial potential for Dr Stephen McColm to develop an enhanced DNA assembly approach based on the company’s proprietary inABLE® technology.
The Roslin Innovation Centre will be the new business location of choice for companies undertaking strategic, commercial and collaborative research in the Animal and Veterinary Sciences, Agri-Tech and One Health industries.
John Mackenzie, CEO of Roslin Innovation Centre, gives an insight into the role of the new business gateway during Edinburgh's Life Sciences focus week, part of Visit Scotland's Legends campaign - Scotland Where #IdeasBecomeLegend.
Roslin Technologies is extending the reach of its advanced animal stem-cell technology with launch of a new venture that will produce and sell high-quality, eco-friendly dog food without the use of farm animals.